Archive

Revocation of vaccine mandates – effective 15th March

Written by Christine Clark | 1 Mar 2022

90% of respondents supported revocation of the vaccine mandate, in a public consultation exercise carried out in February 2022. The UK Government has today (March 1st) published its… read more.

Antibodies improve in quality for months after COVID-19 vaccination

Written by Charlie King | 18 Feb 2022

For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted against the virus that causes COVID-19, according… read more.

Implications of findings for disease flare and vaccine reactions in RMD patients

Written by Christine Clark | 8 Feb 2022

With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at… read more.

Disease flare and reactogenicity after covid vaccination in RMD patients

Written by Christine Clark | 7 Feb 2022

A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the… read more.

Are hedgehogs to blame for superbugs?

Written by Gary Finnegan | 10 Jan 2022

The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.

Don’t bet on lottery to boost vaccine uptake

Written by Gary Finnegan | 9 Jan 2022

Most people offered a COVID-19 vaccine in 2021 kept their appointment and rolled up their sleeves. However, as the year wore on, some countries struggled with vaccine hesitancy…. read more.

New study associates mask laws to reduction of COVID-19 deaths

Written by Charlie King | 28 Dec 2021

Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine. A… read more.

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by Charlie King | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease,… read more.

Molnupiravir – what you need to know

Written by Christine Clark | 10 Dec 2021

Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at… read more.

COVID-19 vaccination much more effective at preventing hospitalization than prior infection only

Written by Bruce Sylvester | 18 Nov 2021

COVID-19 vaccination is about five times more effective at preventing COVID-related hospitalization than prior infection only, researchers reported on Oct. 29, 2021 in Morbidity and Mortality Weekly Report,… read more.

Moderna provides update on timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for adolescents

Written by Charlie King | 4 Nov 2021

Moderna, Inc. provided an update that the FDA has notified the Company that it will require additional time to complete its assessment of Moderna’s Emergency Use Authorization (EUA)… read more.

Safety analysis of biologics and highlighting vaccine hesitancy: real-world data shines a light on the impact of COVID-19 on psoriasis patients

Written by Charlie King | 11 Oct 2021

Real-world data looking at biologic treatment and vaccine hesitancy in psoriasis patients is being presented at EADV’s 30th Congress. The findings of two studies are helping to advance… read more.

« Previous 1 … 4 5 6 7 8 … 34 Next »

Archive

Subscribe for our mailing list

Follow Us